CS Reducer study for heart failure with preserved pumping function
Part of Heart & circulation clinical trials.
This trial is testing a device called CS Reducer to see if it can help people with a certain type of heart failure (HFpEF) and a problem with small blood vessels in the heart (CMD). The device may improve blood flow and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must already be signed up for the main CS Reducer HFpEF study (IRB number 25-002292).
- You cannot have any metal implants that would make an MRI unsafe.
- You must be able and willing to give written informed consent.
- You have been diagnosed with heart failure with preserved pumping function (HFpEF) and coronary microvascular dysfunction (CMD).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special exercise MRI to see how the heart works during activity in people with a type of heart failure where the heart's pumping strength is normal. It also includes people with shortness of breath from other causes and healthy volunteers to compare results.
This study uses a detailed heart MRI (called CMR) to better recognize a type of heart failure where the heart pumps normally but doesn't relax properly. It aims to improve diagnosis and understanding of this condition, which could lead to better treatment for patients.
This trial tests a device placed in a heart vein to improve symptoms in people whose heart pumps normally but still causes shortness of breath and fatigue. The device may help relieve pressure in the heart and improve daily life.
This study looks at how a pacemaker-like device (cardiac resynchronization therapy) affects heart function in people with heart failure and reduced ejection fraction. It may help you understand if this treatment is right for you and could improve your heart health.
This study tests a heart device (CCM) plus standard medications to see if the combination helps people with a weak heart pump. It's for those whose heart function is low and who still have symptoms despite current treatment.
This study tests a therapy called Cardiac Contractility Modulation (CCM) for people with heart failure. It uses a device to help the heart pump more strongly, and researchers compare it to standard care using patient records.
Hear when a new Heart Failure With Preserved Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.